Richard C. Woodman
Direttore/Membro del Consiglio presso H3 Biomedicine, Inc.
Profilo
Richard C.
Woodman is currently the Director at H3 Biomedicine, Inc. He previously worked as the Senior Director-Medical at Johnson & Johnson from 2002 to 2006, and as the Head-US Oncology Clinical Development at Novartis, Inc. from 2006 to 2018.
He also served as the Chief Clinical Officer-Oncology Business Group at Eisai Co., Ltd.
and as the Chief Medical Officer, SVP-Research & Development at Onconova Therapeutics, Inc. from 2018 to 2021.
Prior to his industry career, he was a Professor at the University of Calgary.
Woodman received his undergraduate degree from the University of British Columbia and his doctorate from the University of Calgary in 1981.
Posizioni attive di Richard C. Woodman
| Società | Posizione | Inizio |
|---|---|---|
H3 Biomedicine, Inc.
 H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Direttore/Membro del Consiglio | 11/01/2022 |
Precedenti posizioni note di Richard C. Woodman
| Società | Posizione | Fine |
|---|---|---|
| TRAWS PHARMA, INC. | Direttore Tecnico/Scientifico/R&S | 15/01/2021 |
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Direttore Tecnico/Scientifico/R&S | 01/03/2018 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01/01/2006 |
| EISAI CO., LTD. | Corporate Officer/Principal | - |
| University of Calgary | Corporate Officer/Principal | - |
Formazione di Richard C. Woodman
| University of Calgary | Doctorate Degree |
| University of British Columbia | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| TRAWS PHARMA, INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| EISAI CO., LTD. | Health Technology |
| Aziende private | 2 |
|---|---|
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Health Technology |
H3 Biomedicine, Inc.
H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Health Technology |
- Borsa valori
- Insiders
- Richard C. Woodman
